Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAIN-CONTRoLS: Comparative Effectiveness in CSPN
NCT02260388Phase 4Completed
- Sponsor
- University of Kansas Medical Center
- Start
- Oct 2014
- Primary completion
- Sep 2017
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 4 trial of nortriptyline, duloxetine, pregabalin, mexiletine in sensory polyneuropathy, sponsored by University of Kansas Medical Center. Started Oct 2014; status: completed.
02
Drugs
nortriptylineduloxetinepregabalinmexiletine
03
Conditions
sensory polyneuropathy
Beyond the preview
Go deeper on NCT02260388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02260388.